Your browser doesn't support javascript.
loading
Role of the CYP3A4-mediated 11,12-epoxyeicosatrienoic acid pathway in the development of tamoxifen-resistant breast cancer.
Thuy Phuong, Nguyen Thi; Kim, Ji Won; Kim, Jung-Ae; Jeon, Jang Su; Lee, Ji-Yoon; Xu, Wen Jun; Yang, Jin Won; Kim, Sang Kyum; Kang, Keon Wook.
Afiliação
  • Thuy Phuong NT; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, South Korea.
  • Kim JW; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, South Korea.
  • Kim JA; College of Pharmacy, Yeungnam University, Gyeongsan 38541, South Korea.
  • Jeon JS; College of Pharmacy, Chungnam National University, Daejeon 34134, South Korea.
  • Lee JY; College of Pharmacy, Chungnam National University, Daejeon 34134, South Korea.
  • Xu WJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, South Korea.
  • Yang JW; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, South Korea.
  • Kim SK; College of Pharmacy, Chungnam National University, Daejeon 34134, South Korea.
  • Kang KW; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, South Korea.
Oncotarget ; 8(41): 71054-71069, 2017 Sep 19.
Article em En | MEDLINE | ID: mdl-29050342

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article